HANTSON LUDWIG bought IONS

July 15, 2026 · Form 4 insider transaction

HANTSON LUDWIG bought 3,399 shares of Ionis Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
3,399
Price
$0.00
Total value
N/A
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJuly 15, 2026
Filing dateJuly 17, 2026
Shares owned after3,399
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.; Grant on July 15, 2026 to reporting person of Restricted Stock Unit Award under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in three equal annual installments, the first installment vesting on July 15, 2027. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 15, 2029. The RSU is vested as to 0 shares on July 15, 2026.

View the original Form 4 on SEC EDGAR